Key points are not available for this paper at this time.
Objective: This review aims to examine the role of telemedicine in facilitating access to medication-induced abortion services, in the context of legal restrictions, geographical barriers, and the impact of the coronavirus disease 2019 (COVID-19) pandemic on healthcare delivery. Mechanism: This study conducted a narrative literature review focusing on the application of telemedicine in abortion care. It included analyzing various study types and evidence from peer-reviewed articles to evaluate the effectiveness, safety, and patient reception of telemedicine in providing medication-induced abortion. Findings in Brief: Medication-induced abortion via telemedicine is safe, effective, and well received by patients, offering a viable alternative to traditional in-person services. Telemedicine enables remote eligibility assessment, medication prescription, and follow-up care, significantly benefiting isolated or underserved populations. Conclusions: Telemedicine has emerged as a critical innovation in abortion care, enhancing access, safety, and equity in abortion services. It addresses significant barriers such as travel expenses and missed work, providing a patient-centered approach to abortion care. Future directions should focus on optimizing telemedicine protocols and expanding access to underserved populations, ensuring comprehensive abortion care through telemedicine.
Wen et al. (Mon,) studied this question.